BRUKER CORPBRKR

時価総額
$71.7億
PER
高性能科学機器と分析・診断ソリューションの大手。磁気共鳴、質量分析、空間生物学のプラットフォームを展開。2024年にELITechGroup、NanoString、Chemspeedを買収。北米・欧州・アジアで販売拠点を展開。
2011年
12月31日
2012年
12月31日
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
2024年
12月31日
Consolidated net income9478826010515580181198161281299429114
Depreciation and amortization535961605354646576808989115184
Stock-based compensation expense8879891111101617282425
Deferred income taxes-5-127------2-22-6-15-24-64
Bargain purchase gain on acquisition and associated measurement period adjustments--------------8
Asset Impairment Charges-24-125-------2229
Loss on sale of minority investment------------7-
Gain (loss) on sale of property, plant and equipment------------9-5
Other non-cash expenses, net-1-5-2-3---------32-29
Accounts receivable53-21915-45856315-419568141
Inventories11250-6-554373660926713812570
Accounts payable9------------21
Income taxes payable, net--2-34623-27541343-44-744-15
Deferred revenue and customer advances--45134547-172024-1-53
Customer advances---------521928--
Other changes in operating assets and liabilities, net-4-2934-12-6-450-1119-328-79
Net cash provided by operating activities------154240213332282274350251
Purchases of property, plant and equipment5473503434374449739792129107115
Maturity of short-term investments-------117-10698100--
Proceeds from sale of minority investment-------------15-
Cash paid for minority investments-----------602548
Cash paid for acquisitions, net of cash acquired14271242924661929059651822271,600
Proceeds from sales of property, plant and equipment-31311120110514111
Net proceeds from cross-currency swap agreements----------9-10-6-6-5
Net cash used in investing activities-------30-123-158-193-192-252-326-1,757
Repayments of revolving lines of credit------130218362305---1,213
Proceeds from Lines of Credit------154129251298---1,250
Repayment of long-term debt29832110----1--135
Proceeds from long-term debt----------493--974
Payment of deferred financing costs11------400--6
Proceeds from Issuance Initial Public Offering-------------403
Proceeds from Issuance of Common Stock3588111220911373106
Payment of contingent consideration-------2680335
Payment of dividends to common shareholders-----262525252524302930
Repurchase of common stock----90160152-142123153263152-
Proceeds from (Payments to) Noncontrolling Interests------------3-15
Net cash provided by (used in) financing activities-------159-112300-162319-415-1931,230
Effect of exchange rate changes on cash, cash equivalents and restricted cash------18-6126-22-3012-29
Net change in cash, cash equivalents and restricted cash-------17-33564386-423-157-305
Cash paid for interest------1512162920243455
Income Taxes Paid7080845657725361614314614797154